SERAFIN, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 468
AS - Asia 267
EU - Europa 250
OC - Oceania 2
Totale 987
Nazione #
US - Stati Uniti d'America 468
SG - Singapore 137
IT - Italia 110
HK - Hong Kong 70
GB - Regno Unito 43
CN - Cina 42
FI - Finlandia 25
DE - Germania 24
LT - Lituania 16
ID - Indonesia 14
SE - Svezia 11
FR - Francia 6
CZ - Repubblica Ceca 4
BG - Bulgaria 3
AU - Australia 2
CH - Svizzera 2
NL - Olanda 2
TR - Turchia 2
UA - Ucraina 2
IE - Irlanda 1
IN - India 1
KR - Corea 1
RU - Federazione Russa 1
Totale 987
Città #
Santa Clara 199
Singapore 121
Hong Kong 70
Ashburn 48
Woodbridge 30
Fairfield 23
New York 22
Helsinki 20
Modena 20
Chandler 17
Bologna 16
Southend 16
Jakarta 14
Wilmington 12
Houston 11
Nyköping 11
Beijing 10
Shanghai 10
Kilburn 9
Munich 9
Cambridge 8
Padova 8
Seattle 8
Torre del Greco 7
Dallas 6
Glasgow 6
San Diego 5
Bari 4
Dearborn 4
Falls Church 4
Formigine 4
Frattamaggiore 4
Lappeenranta 4
Paris 4
Reggio Emilia 4
Brno 3
Carpi 3
Los Angeles 3
Princeton 3
Sofia 3
Ann Arbor 2
Assago 2
Cascina 2
Chiampo 2
Chicago 2
Curtatone 2
Hounslow 2
Jiaxing 2
London 2
Milan 2
Prescot 2
Prignano sulla Secchia 2
Turin 2
Zurich 2
Acton 1
Amsterdam 1
Bad Bellingen 1
Buffalo 1
Cedar Knolls 1
Chiswick 1
Clifton 1
Dublin 1
Eugene 1
Frankfurt am Main 1
Fuzhou 1
Grafing 1
Guangzhou 1
Gunzenhausen 1
Hefei 1
Izmir 1
Jacksonville 1
Lanzo d'Intelvi 1
Moscow 1
New Delhi 1
Norwalk 1
Olomouc 1
Osnabrück 1
Rome 1
Roncoferraro 1
Sarno 1
Southwark 1
Sydney 1
Taiyuan 1
Torre Pellice 1
Wandsworth 1
Totale 842
Nome #
Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL 176
Editorial: Special Issue on Innovative Multi-Disciplinary Approaches for Precision Studies in Leukemia 73
Synergistic cytotoxicity of dual PI3K/mTOR and FLT3 inhibition in FLT3-ITD AML cells 66
Targeting metabolic vulnerabilities and aberrant signal transduction pathways in paediatric T-cell Acute Lymphoblastic Leukaemia (T-ALL) 51
Improved efficacy of quizartinib in combination therapy with PI3K inhibition in primary FLT3-ITD AML cells 47
Functional relevance of circRNA aberrant expression in pediatric acute leukemia with KMT2A::AFF1 fusion 37
CircFBXW7 in patients with T-cell ALL: depletion sustains MYC and NOTCH activation and leukemia cell viability 25
A rhabdomyosarcoma hydrogel model to unveil cell-extracellular matrix interactions 25
Epigenetic heterogeneity affects the risk of relapse in children with t(8;21)RUNX1-RUNX1T1-rearranged AML 23
Proteomic Alterations in Response to Hypoxia Inducible Factor 2α in Normoxic Neuroblastoma Cells 22
Emerging Epigenetic and Posttranslational Mechanisms Controlling Resistance to Glucocorticoids in Acute Lymphoblastic Leukemia 22
Differential expression of hERG1A and hERG1B genes in pediatric acute lymphoblastic leukemia identifies different prognostic subgroups 20
Choline kinase alpha inhibition by EB-3D triggers cellular senescence, reduces tumor growth and metastatic dissemination in breast cancer 20
Large-scale circular RNA deregulation in T-ALL: Unlocking unique ectopic expression of molecular subtypes 20
Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia 20
A perfusion-based three-dimensional cell culture system to model alveolar rhabdomyosarcoma pathological features 20
Notch3 signalling promotes tumour growth in colorectal cancer 20
Cancer-specific CTCF binding facilitates oncogenic transcriptional dysregulation 19
A positive feedback loop regulation between NOTCH1 and USP11 in T-cell leukemia 19
Targeting NOTCH1 in combination with antimetabolite drugs prolongs life span in relapsed pediatric and adult T-acute lymphoblastic leukemia xenografts 19
Phosphoproteomic Analysis Reveals a Different Proteomic Profile in Pediatric Patients With T-Cell Lymphoblastic Lymphoma or T-Cell Acute Lymphoblastic Leukemia 18
Deciphering KRAS and NRAS mutated clone dynamics in MLL-AF4 paediatric leukaemia by ultra deep sequencing analysis 18
AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells 18
Interleukin-22 in the diagnosis of active chronic graft-versus-host disease in paediatric patients 18
NOTCH3 SIGNALING REGULATES MUSASHI-1 EXPRESSION IN METASTATIC COLORECTAL CANCER CELLS 18
Myc Is a Metastasis Gene for Non-Small-Cell Lung Cancer 18
EB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells 17
MODULATION OF MICRORNA EXPRESSION IN HUMAN T CELL DEVELOPMENT: TARGETING OF NOTCH3 BY MIR-150 16
NUP214-ABL1 fusion in childhood T-ALL 15
Ruxolitinib as a novel therapeutic option for poor prognosis t-lbl pediatric patients 15
SYK targeting represents a potential therapeutic option for relapsed resistant pediatric ETV6-RUNX1 B-acute lymphoblastic leukemia patients 15
RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit 14
Correction: A positive feedback loop regulation between NOTCH1 and USP11 in T-cell leukemia (Leukemia, (2023), 10.1038/s41375-023-02096-4) 13
Modulation of microRNA expression in human T-cell development: Targeting of NOTCH3 by miR-150 13
Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in Leukemia 13
SF3B1 homeostasis is critical for survival and therapeutic response in T cell leukemia 13
USP7 cooperates with NOTch1 to drive the oncogenic transcriptional program in T-cell leukemia 12
Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia 11
Pre-clinical evaluation of second generation pim inhibitors for the treatment of t-cell acute lymphoblastic leukemia and lymphoma 9
Totale 1.028
Categoria #
all - tutte 11.677
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.677


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202033 0 0 0 0 5 7 7 4 5 2 3 0
2020/202129 4 1 1 4 3 0 2 7 1 4 2 0
2021/202272 1 2 3 9 5 9 8 3 7 6 14 5
2022/202368 8 5 6 2 5 8 0 8 12 1 7 6
2023/2024372 1 1 41 62 59 15 32 53 12 23 27 46
2024/2025397 58 11 9 78 241 0 0 0 0 0 0 0
Totale 1.028